Biosimilars
Article
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Article
Key considerations to support a robust biosimilar marketplace
We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.
Read More
Newsroom
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Article
Express Scripts To Begin Adding Inflammatory Conditions Biosimilars to Largest Formularies Next Year
December 05, 2022
Article
The Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
November 28, 2022
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Video
Strategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read More